APU
PFE icon

Alpine Partners USVI’s Pfizer PFE Stock Holding History

Alpine Partners USVI’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-158,100
Closed -$4.31M – 37
2013
Q3 		$4.31M Buy
+158,100
New +$4.3M 16.16% 1

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Alpine Partners USVI's PFE Position: Q4 2013 in Review

Alpine Partners USVI sold out of Pfizer (PFE) in Q4 2013, closing a stake of 158,100 shares — an estimated $4.31M sold.

Alpine Partners USVI first reported a position in PFE in Q3 2013 and held it in 1 quarter. The position peaked at $4.31M in Q3 2013. 1,735 funds tracked by Wall St. Rank hold PFE as of Q4 2013.

  • Alpine Partners USVI reported no remaining Pfizer position as of Q4 2013 after selling out during the quarter.
  • Alpine Partners USVI sold 158,100 Pfizer shares in Q4 2013, an estimated $4.31M.
  • Alpine Partners USVI first reported a position in Pfizer in Q3 2013 and held it in 1 quarter.
  • Alpine Partners USVI's Pfizer position peaked at $4.31M in Q3 2013.
  • 1,735 funds tracked by Wall St. Rank held Pfizer as of Q4 2013.

Based on Alpine Partners USVI's 13F filing for Q4 2013, filed 14 Feb 2014.